Ectonucleoside Triphosphate Diphosphohydrolase 1 (ENTPD1) Antibody (PE)

Este producto es parte de ENTPD1 - ectonucleoside triphosphate diphosphohydrolase 1
Product Graph
520€ (100 tests)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Ectonucleoside Triphosphate Diphosphohydrolase 1 (ENTPD1) Antibody (PE)
category
Primary Antibodies
provider
Abbexa
reference
abx412895
tested applications
FCM

Description

Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39) Antibody (PE) is a Mouse Monoclonal antibody against Ectonucleoside Triphosphate Diphosphohydrolase 1 (CD39).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Ectonucleoside Triphosphate Diphosphohydrolase 1 (ENTPD1)
Host
Mouse
Reactivity
Human
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Clonality
Monoclonal
Conjugation
PE
Isotype
IgG1
Purification
Purified
Size 1
100 tests
Form
Lyophilized
Tested Applications
FCM
Buffer
PBS, 1% BSA. Contains sodium azide.
Availability
Shipped within 3-7 working days.
Storage
Store at -20 °C or -80 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P49961
Alias
CD39,SPG64,ATP-DPH,ATPDase,NTPDase-1,ATP diphosphohydrolase,Ecto-ATP diphosphohydrolase 1,Ecto-apyrase,Lymphoid cell activation antigen ,Nucleoside triphosphate diphosphohydrolase 1
Background
Antibody anti-ENTPD1
Status
RUO

Descripción

ENTPD1, also known as CD39, is a critical ectoenzyme involved in the regulation of extracellular nucleotide levels. It belongs to the family of ectonucleoside triphosphate diphosphohydrolases (E-NTPDases) that hydrolyze extracellular nucleotides, such as ATP and ADP, into their respective monophosphate forms (AMP). This enzymatic activity is crucial for modulating purinergic signaling, which is involved in various physiological processes, including immune responses, thrombosis, vascular function, and tissue homeostasis. ENTPD1 is primarily expressed on immune cells like T regulatory cells (Tregs), dendritic cells, macrophages, and endothelial cells. Its ability to degrade ATP and ADP limits pro-inflammatory and pro-thrombotic signaling, promoting an anti-inflammatory and antithrombotic environment. This makes ENTPD1 a significant player in maintaining immune tolerance, regulating inflammation, and controlling thrombosis.

Related Products

EH2435

Human ENTPD1 (Ectonucleoside triphosphate diphosphohydrolase 1) ELISA Kit

Ver Producto
FNab01474

ENTPD1 antibody

ENTPD1(Ectonucleoside triphosphate diphosphohydrolase 1) is also named as CD39, NTPDase 1, Ecto-ATPDase 1 and belongs to the GDA1/CD39 NTPase family. In the nervous system, it can hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission.It is a noncovalent tetrameric protein and that detergent inhibition of enzymatic activity is caused by dissociation of ectoapyrase tetramers into monomers(PMID: 9733785).And it is a 70-to 100-kDa protein that is heavily N-glycosylated(PMID:7930580). It has 3 isoforms produced by alternative splicing. CD39 preferentially occurred as a dimer that could be dissociated into monomeric forms.(PMID: 12694193). The soluble isoform of CD39(38-478 amino acid) locates to the extracellular part and FNab01474 recognizes both the 3 isoforms and soluble form of CD39(38-478aa) molecule.

Ver Producto
FNab02780

ENTPD1 antibody

In the nervous system, could hydrolyze ATP and other nucleotides to regulate purinergic neurotransmission. Could also be implicated in the prevention of platelet aggregation by hydrolyzing platelet-activating ADP to AMP. Hydrolyzes ATP and ADP equally well.

Ver Producto